(Q38470623)

3 September 2017

title

Genotypic and phenotypic resistance testing of HIV-1 in routine clinical care (English)

1 reference

3 September 2017

Hirsch HH

1

1 reference

3 September 2017

Drechsler H

2

1 reference

3 September 2017

Holbro A

3

1 reference

3 September 2017

Hamy F

4

1 reference

3 September 2017

Sendi P

5

1 reference

3 September 2017

Petrovic K

6

1 reference

3 September 2017

Klimkait T

7

1 reference

3 September 2017

Battegay M

8

1 reference

3 September 2017

publication date

1 November 2005

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

3 September 2017

published in

1 reference

3 September 2017

volume

24

1 reference

3 September 2017

issue

11

1 reference

3 September 2017

page(s)

733-738

1 reference

HIV-1 protease and reverse transcriptase mutation patterns responsible for discordances between genotypic drug resistance interpretation algorithms

3 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10096-005-0044-4

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy.

21 January 2018

1 reference

12 December 2020

A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy. CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

12 December 2020

Clinical utility of HIV-1 genotyping and expert advice: the Havana trial

1 reference

12 December 2020

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

1 reference

12 December 2020

Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance

1 reference

12 December 2020

Drug-resistance genotyping in HIV-1 therapy: the VIRADAPT randomised controlled trial.

1 reference

12 December 2020

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial

1 reference

12 December 2020

Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms

1 reference

12 December 2020

Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study.

1 reference

12 December 2020

A sensitive replicative system to assess HIV-1 drug resistance

1 reference

12 December 2020

Impact of protease polymorphisms and viral fitness on human immunodeficiency virus (HIV) type 1 viremia in untreated HIV-1 infection

1 reference

12 December 2020

Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial

1 reference

12 December 2020

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

1 reference

12 December 2020

10.1007/S10096-005-0044-4

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1001176738

0 references

1 reference